Alkermes
Alkermes plc, a leading biopharmaceutical company headquartered in Ireland, focuses on developing innovative therapies for central nervous system (CNS) disorders and addiction. Founded in 1987, Alkermes has established a strong presence in the global healthcare market, with significant operations in the United States and Europe. The company is renowned for its unique drug delivery technologies and a robust portfolio of products, including treatments for schizophrenia, depression, and opioid dependence. Alkermes' commitment to addressing complex medical needs has positioned it as a key player in the biopharmaceutical industry, with notable achievements in advancing patient care through its proprietary formulations. With a focus on scientific excellence and patient-centric solutions, Alkermes continues to drive innovation and improve outcomes for individuals affected by serious mental health conditions.
DitchCarbon Score
How does Alkermes's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alkermes's score of 15 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Alkermes's reported carbon emissions
In 2023, Alkermes reported greenhouse gas emissions of approximately 250 kg CO2e per employee and 50 kg CO2e per square metre of floor area, reflecting their Scope 1 and 2 emissions. The company also reported emissions of about 1.5e-07 kg CO2e per million dollars of revenue. In 2021, the emissions metrics were 7.0 kg CO2e per square metre and 3.0e-06 kg CO2e per million dollars of revenue, indicating a significant improvement in their emissions efficiency. Despite these metrics, Alkermes has not disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests that while they are tracking emissions, they may not have formalised strategies in place to achieve specific reductions. As a company headquartered in Ireland (IE), Alkermes is positioned within an industry increasingly focused on sustainability and climate action, aligning with global trends towards reducing carbon footprints.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alkermes is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
